Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Insulin pumps are small, computerized, portable devices that attach to the body and are programmed to deliver specific amounts of insulin continuously throughout the day. They are primarily used by ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

The NovoPen Echo smart insulin pen now works with Dexcom CGM. [Image from Novo Nordisk] Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes (PLWD), ...

The Disposable Insulin-Delivery Device Market is experiencing significant growth, driven by the rising prevalence of diabetes. The market, currently valued at USD 15,780.6 million in 2023, is ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

The global market for disposable insulin-delivery devices achieved a valuation of US$ 14,585.6 million in 2022. As we step into 2023, the market is poised to increase further, with an estimated value ...

In 2022, the global market size for Disposable Insulin-Delivery Devices reached a substantial US$ 14,585.6 million. As we progress through 2023, the market’s value is projected to climb even higher to ...